Moderna reports 'positive' results from coronavirus vaccine trial

The company leading the race to develop a coronavirus vaccine announced “positive” early findings on Monday, with participants producing antibodies to ward off the disease. Biotech company Moderna Inc. dosed 45 patients between the ages of 18 and 55 with 25, 100 or 250 micrograms of its experimental drug. After receiving a second booster shot,...